Wellnex Life Limited (AIM: WNX, ASX: WNX)*: Sale of Pain Away for up to A$21.3mProBiotix Health plc (AQSE: PBX): 1H 2025 unaudited interim resultsSolvonis Therapeutics plc (LSE: SVNS): SVN-015 advances into further NIDA-funded studies
06 Aug 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
Solvonis Therapeutics Plc (SVNS:LON), 0.1 | Probiotix Health Plc (X90:FRA), 0 | Wellnex Life Ltd (WNX:ASX), 0
- Published:
06 Aug 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
4 -
Wellnex Life Limited (AIM: WNX, ASX: WNX)*: Sale of Pain Away for up to A$21.3mProBiotix Health plc (AQSE: PBX): 1H 2025 unaudited interim resultsSolvonis Therapeutics plc (LSE: SVNS): SVN-015 advances into further NIDA-funded studies